Changes in Macula Lutea Following Nd: YAG Laser Capsulotomy in OCT Imaging
|Halás M Jr.*, SvoreÅova I, KrajÄova P, Oláh Z, StrmeÅ P, and Krásnik V|
|Department of Ophthalmology, University Hospital Bratislava, Comenius University, Bratislava, Slovakia|
|Corresponding Author :||MUDr. Halás Marián
Department of Ophthalmology
University Hospital Bratislava
Šancova 54, 81105 Bratislava, Slovakia
E-mail: [email protected]
|Received October 23, 2012; Accepted November 22, 2012; Published November 28, 2012|
|Citation: Halás M Jr, Svorenova I, Krajcova P, Oláh Z, Strmen P, et al. (2012) Changes in Macula Lutea Following Nd: YAG Laser Capsulotomy in OCT Imaging. J Clin Exp Ophthalmol 3:256. doi:10.4172/2155-9570.1000256|
|Copyright: © 2012 Halás M Jr, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at
Pubmed Scholar Google
Objectives: To evaluate functional and anatomical changes in macular region after Nd:YAG capsulotomy.
Background: Optical coherence tomography (OCT) enables to visualize, compare and evaluate macular region of retina.
Method: 36 patients, 17 men and 19 women (40 eyes) with posterior capsule opacification underwent Nd:YAG capsulotomy. Average age was 78.2 ± 13 years. Day 1 after procedure and after 1 month best corrected visual acuity (BCVA), intra ocular pressure (IOP), foveal minimal thickness (FMT) and macular volume (MV) were evaluated. Diclophenacum natricum drops (Uniclophen 0.1%) for 3 weeks QID were administered.
Results: Average BCVA in day 1 was 0.71, median 0.50, after 1 month was 0.80, median 0.67. Average MFT in day 1 was 197.63 ± 10.3 μm, median 189 ± 9 μm and after 1 month was 189.63 ± 11.5 μm, median 184 ± 9 μm. Average IOP 15.41 torr, median 15 torr and after 1 month 15.72 torr, median 16 torr. Average MV in day 1 was 6.53 mm3 and after 1 month was 6.51 mm3. Conclusion: Nd:YAG capsulotomy is safe method to remove posterior capsule opacification and improve BCVA. FMT and MV are sensitive parameters that correlate with BCVA. Changes in FMT and MV were nonsignificant.